# Broadwind, Inc.: financial statements, quarterly

BWEN · Nasdaq · CIK 1120370 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwen.md) · [Financials](/companies/bwen/financials.md) · [Filings](/companies/bwen/filings.md) · [Insiders](/companies/bwen/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwen/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [57.2](/filings/0001437749-24-034974.md) | [46.6](/filings/0001437749-24-006588.md) | [36.8](/filings/0001437749-26-016321.md) | [36.5](/filings/0001437749-25-026122.md) | [35.5](/filings/0001437749-25-034781.md) | [33.6 d](/filings/0001437749-26-007742.md) | [36.8](/filings/0001437749-26-016321.md) | [14.5](/filings/0001437749-26-027061.md) | [44.2](/filings/0001437749-25-034781.md) | [37.7 d](/filings/0001437749-26-007742.md) | [34.1](/filings/0001437749-26-016321.md) | [24.3](/filings/0001437749-26-027061.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [10.2](/filings/0001437749-24-034974.md) | [7.0](/filings/0001437749-24-006588.md) | [6.6](/filings/0001437749-25-016392.md) | [5.6](/filings/0001437749-25-026122.md) | [5.2](/filings/0001437749-25-034781.md) | [3.8 d](/filings/0001437749-26-007742.md) | [4.3](/filings/0001437749-26-016321.md) | [1.0](/filings/0001437749-26-027061.md) | [4.5](/filings/0001437749-25-034781.md) | [3.3 d](/filings/0001437749-26-007742.md) | [4.7](/filings/0001437749-26-016321.md) | [3.8](/filings/0001437749-26-027061.md) |
| Selling, general and administrative | $m | [4.6](/filings/0001437749-24-034974.md) | [4.6 d](/filings/0001437749-25-006301.md) | [4.4](/filings/0001437749-25-016392.md) | [4.1](/filings/0001437749-25-026122.md) | [3.9](/filings/0001437749-25-034781.md) | [3.9 d](/filings/0001437749-26-007742.md) | [4.0](/filings/0001437749-26-016321.md) | [3.2](/filings/0001437749-26-027061.md) | [3.8](/filings/0001437749-25-034781.md) | [3.2 d](/filings/0001437749-26-007742.md) | [4.2](/filings/0001437749-26-016321.md) | [3.9](/filings/0001437749-26-027061.md) |
| Operating income | $m | [5.4](/filings/0001437749-24-034974.md) | [2.3](/filings/0001437749-24-006588.md) | [0.2](/filings/0001437749-26-016321.md) | [1.3](/filings/0001437749-25-026122.md) | [1.2](/filings/0001437749-25-034781.md) | [(0.3) d](/filings/0001437749-26-007742.md) | [0.2](/filings/0001437749-26-016321.md) | [(2.4)](/filings/0001437749-26-027061.md) | [8.7](/filings/0001437749-25-034781.md) | [(0.1) d](/filings/0001437749-26-007742.md) | [0.4](/filings/0001437749-26-016321.md) | [(0.2)](/filings/0001437749-26-027061.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-034974.md) | [0.2 d](/filings/0001437749-25-006301.md) | [0.0](/filings/0001437749-25-016392.md) | [0.1](/filings/0001437749-25-026122.md) | [0.0](/filings/0001437749-25-034781.md) | [(0.1) d](/filings/0001437749-26-007742.md) | [0.0](/filings/0001437749-26-016321.md) | [0.0](/filings/0001437749-26-027061.md) | [0.0](/filings/0001437749-25-034781.md) | [(0.0) d](/filings/0001437749-26-007742.md) | [0.1](/filings/0001437749-26-016321.md) | [0.0](/filings/0001437749-26-027061.md) |
| Net income | $m | [4.4](/filings/0001437749-24-034974.md) | [1.1](/filings/0001437749-24-006588.md) | [1.5](/filings/0001437749-25-034781.md) | [0.5](/filings/0001437749-25-034781.md) | [0.1](/filings/0001437749-25-034781.md) | [(0.9) d](/filings/0001437749-26-007742.md) | [(0.4)](/filings/0001437749-26-027061.md) | [(1.0)](/filings/0001437749-26-027061.md) | [7.5](/filings/0001437749-25-034781.md) | [(0.9) d](/filings/0001437749-26-007742.md) | [(0.5)](/filings/0001437749-26-027061.md) | [(0.6)](/filings/0001437749-26-027061.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001437749-24-034974.md) | not reported | [0.07](/filings/0001437749-25-016392.md) | [0.02](/filings/0001437749-25-026122.md) | [0.00](/filings/0001437749-25-034781.md) | not reported | [(0.02)](/filings/0001437749-26-016321.md) | [(0.04)](/filings/0001437749-25-026122.md) | [0.32](/filings/0001437749-25-034781.md) | not reported | [(0.02)](/filings/0001437749-26-016321.md) | not reported |
| Basic EPS | $ per share | [0.21](/filings/0001437749-24-034974.md) | not reported | [0.07](/filings/0001437749-25-016392.md) | [0.02](/filings/0001437749-25-026122.md) | [0.00](/filings/0001437749-25-034781.md) | not reported | [(0.02)](/filings/0001437749-26-016321.md) | [(0.04)](/filings/0001437749-26-027061.md) | [0.32](/filings/0001437749-25-034781.md) | not reported | [(0.02)](/filings/0001437749-26-016321.md) | [(0.03)](/filings/0001437749-26-027061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.7](/filings/0001437749-23-031565.md) | [1.1](/filings/0001437749-25-006301.md) | [1.1](/filings/0001437749-24-016574.md) | [0.9](/filings/0001437749-24-026316.md) | [1.4](/filings/0001437749-24-034974.md) | [7.7](/filings/0001437749-26-007742.md) | [1.2](/filings/0001437749-25-016392.md) | [1.0](/filings/0001437749-25-026122.md) | [1.2](/filings/0001437749-25-034781.md) | [0.5](/filings/0001437749-26-027061.md) | [0.9](/filings/0001437749-26-016321.md) | [17.0](/filings/0001437749-26-027061.md) |
| Current assets | $m | [99.7](/filings/0001437749-23-031565.md) | [69.7](/filings/0001437749-25-006301.md) | [58.3](/filings/0001437749-24-016574.md) | [59.2](/filings/0001437749-24-026316.md) | [62.1](/filings/0001437749-24-034974.md) | [66.9](/filings/0001437749-26-007742.md) | [68.1](/filings/0001437749-25-016392.md) | [78.3](/filings/0001437749-25-026122.md) | [68.6](/filings/0001437749-25-034781.md) | [64.3](/filings/0001437749-26-027061.md) | [64.6](/filings/0001437749-26-016321.md) | [77.0](/filings/0001437749-26-027061.md) |
| Total assets | $m | [165](/filings/0001437749-23-031565.md) | [135](/filings/0001437749-25-006301.md) | [123](/filings/0001437749-24-016574.md) | [123](/filings/0001437749-24-026316.md) | [125](/filings/0001437749-24-034974.md) | [128](/filings/0001437749-26-007742.md) | [129](/filings/0001437749-25-016392.md) | [131](/filings/0001437749-25-026122.md) | [120](/filings/0001437749-25-034781.md) | [117](/filings/0001437749-26-027061.md) | [118](/filings/0001437749-26-016321.md) | [112](/filings/0001437749-26-027061.md) |
| Current liabilities | $m | [84.4](/filings/0001437749-23-031565.md) | [53.6](/filings/0001437749-25-006301.md) | [39.7](/filings/0001437749-24-016574.md) | [39.2](/filings/0001437749-24-026316.md) | [41.4](/filings/0001437749-24-034974.md) | [43.6](/filings/0001437749-26-007742.md) | [45.1](/filings/0001437749-25-016392.md) | [51.3](/filings/0001437749-25-026122.md) | [34.8](/filings/0001437749-25-034781.md) | [31.7](/filings/0001437749-26-027061.md) | [33.6](/filings/0001437749-26-016321.md) | [28.3](/filings/0001437749-26-027061.md) |
| Long-term debt | $m | [6.6](/filings/0001437749-23-031565.md) | [6.3](/filings/0001437749-25-006301.md) | [6.3](/filings/0001437749-24-016574.md) | [5.9](/filings/0001437749-24-026316.md) | [5.6](/filings/0001437749-24-034974.md) | [7.7](/filings/0001437749-26-007742.md) | [7.4](/filings/0001437749-25-016392.md) | [7.0](/filings/0001437749-25-026122.md) | [5.4](/filings/0001437749-25-034781.md) | [4.3](/filings/0001437749-26-027061.md) | [4.8](/filings/0001437749-26-016321.md) | [2.5](/filings/0001437749-26-027061.md) |
| Current portion of debt | $m | [19.8](/filings/0001437749-23-031565.md) | [5.9](/filings/0001437749-25-006301.md) | [1.4](/filings/0001437749-24-016574.md) | [12.0](/filings/0001437749-24-026316.md) | [11.4](/filings/0001437749-24-034974.md) | [1.5](/filings/0001437749-26-007742.md) | [4.8](/filings/0001437749-25-016392.md) | [19.1](/filings/0001437749-25-026122.md) | [4.9](/filings/0001437749-25-034781.md) | [4.7](/filings/0001437749-26-027061.md) | [5.9](/filings/0001437749-26-016321.md) | [0.8](/filings/0001437749-26-027061.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [54.4](/filings/0001437749-24-034974.md) | [56.0](/filings/0001437749-26-007742.md) | [58.0](/filings/0001437749-25-034781.md) | [59.1](/filings/0001437749-25-034781.md) | [59.6](/filings/0001437749-25-034781.md) | [59.4](/filings/0001437749-26-027061.md) | [59.3](/filings/0001437749-26-027061.md) | [59.0](/filings/0001437749-26-027061.md) | [66.9](/filings/0001437749-25-034781.md) | [66.3](/filings/0001437749-26-027061.md) | [66.2](/filings/0001437749-26-027061.md) | [65.8](/filings/0001437749-26-027061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.1) d](/filings/0001437749-24-034974.md) | [15.6 d](/filings/0001437749-25-006301.md) | [5.9](/filings/0001437749-25-016392.md) | [(9.3) d](/filings/0001437749-25-026122.md) | [2.4 d](/filings/0001437749-25-034781.md) | [14.8 d](/filings/0001437749-26-007742.md) | [(8.0)](/filings/0001437749-26-016321.md) | [(12.5) d](/filings/0001437749-25-026122.md) | [4.3 d](/filings/0001437749-25-034781.md) | [0.9 d](/filings/0001437749-26-007742.md) | [2.9](/filings/0001437749-26-016321.md) | [(3.8) d](/filings/0001437749-26-027061.md) |
| Capital expenditure | $m | [1.3](/filings/0001437749-24-034974.md) | [1.1 d](/filings/0001437749-25-006301.md) | [1.7](/filings/0001437749-25-016392.md) | [0.8](/filings/0001437749-24-026316.md) | [0.7](/filings/0001437749-24-034974.md) | [0.3 d](/filings/0001437749-26-007742.md) | [0.9](/filings/0001437749-26-016321.md) | [(0.5) d](/filings/0001437749-26-027061.md) | [2.2 d](/filings/0001437749-25-034781.md) | [1.0 d](/filings/0001437749-26-007742.md) | [2.8](/filings/0001437749-26-016321.md) | [0.5 d](/filings/0001437749-26-027061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.2](/filings/0001437749-23-023550.md) | [20.5](/filings/0001437749-23-031565.md) | [21.4](/filings/0001437749-24-016574.md) | [21.4](/filings/0001437749-24-026316.md) | [21.6](/filings/0001437749-24-034974.md) | [21.8](/filings/0001437749-25-016392.md) | [22.0](/filings/0001437749-25-026122.md) | [22.1](/filings/0001437749-25-034781.md) | [22.4](/filings/0001437749-26-016321.md) | [22.8](/filings/0001437749-25-026122.md) | [23.3](/filings/0001437749-25-034781.md) | [23.3](/filings/0001437749-26-016321.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,657,373 at 2026-08-04, from the cover of the [10-Q filed 2026-08-11](/filings/0001437749-26-027061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.